Campbell and Refractec, of Irvine, CA, were honored with the Silver ABBY Award for the company's proprietary Conductive Keratoplasty
technology for ophthalmologists to effectively treat refractive errors -- the only procedure designed for hyperopia that uses radio frequency instead of a laser.
Kanner joined the company last year to assist in commercializing the ViewPoint(TM) CK System, a device used to perform Conductive Keratoplasty for the treatment of hyperopia.
Refractec is currently conducting Phase III clinical trials in the United States for Conductive Keratoplasty (CK), a minimally invasive non-laser approach for correcting low to moderate hyperopia.
com/ Conductive Keratoplasty
(R) Scientific Papers Saturday, April 16 - Room CC-201 1:07 PM Long-Term Results of Conductive Keratoplasty
to Treat Low to Moderate Hyperopia, Tatiana L.
investigators in anticipation of expanding their Phase III clinical trials of Conductive Keratoplasty
Mitch Campbell, CEO, will present their proprietary, FDA-approved Conductive Keratoplasty
technology, which is the only procedure designed to improve near vision non-invasively, so patients can toss their "readers.
Phase III IDE study of Conductive Keratoplasty for vision correction.
will present his Conductive Keratoplasty data at the 1999 Fall World Refractive Surgery Symposium (ISRS) in Orlando, Fla.
announced that it has initiated numerous international Post-Marketing Studies using Conductive Keratoplasty
(CK) to treat Hyperopia, Presbyopia, Astigmatism and Retreatment of patients with prior alternative refractive procedures.
Clear lensectomy w/ IOL 44% Sclerotomy 29% Conductive Keratoplasty
(CK) 15% LASIK 12%